BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1376846)

  • 21. Does isradipine exert a special early-morning blood pressure-lowering effect?
    Viskoper JR; Laszt A; Faraggi D; Yaskil E
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S74-5. PubMed ID: 1376842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of isradipine on responses to standardized physical stress tests in hypertension of pregnancy.
    Lunell NO; Grunewald C; Nisell H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S99-101. PubMed ID: 1376850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Simone G; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):494-8. PubMed ID: 1839903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined actions of isradipine and captopril on renal function in hypertension.
    Krusell LR; Sihm I; Jespersen LT; Thomsen K; Pedersen EB; Pedersen OL
    J Hum Hypertens; 1992 Oct; 6(5):401-7. PubMed ID: 1464898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of isradipine and nifedipine in chronic sustained hypertension.
    Gross P; Koppenhagen K; Wudel E; Burger KJ; Welzel D; Distler GA
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S84-6. PubMed ID: 1376845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
    Hirakata H; Iino K; Ishida I; Kashiwagi M; Yoshinari M; Okuda S; Fujita S; Fujishima M
    Blood Press Suppl; 1992; 3():124-9. PubMed ID: 1343281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
    Persson B; Andersson OK; Wysocki M; Hedner T; Karlberg B
    J Intern Med; 1992 Mar; 231(3):247-52. PubMed ID: 1532613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol.
    Kantola I; Rauhala E; Erkinjuntti M; Mansury L
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S41-5. PubMed ID: 1720486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies on isradipine in the management of adult hypertensive patients at Moi University Teaching Hospital, Eldoret, Kenya.
    Lore W; Anjichi GM
    East Afr Med J; 1992 Feb; 69(2):69-73. PubMed ID: 1387077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.